WHAT'S HAPPENING AT FAIRMOUNT
Audax Private Equity, a leading alternative investment manager and capital partner, announced that it has made a growth investment in Pyramid Laboratories, Inc. to support the continued growth of the company’s clinical and commercial biologics and advanced therapeutics manufacturing and service operations. Pyramid is a leading drug product contract development and manufacturing organization (“CDMO”).
The MYND Group, a full-service strategic market access marketing company with extensive healthcare industry expertise in pharmaceuticals and biologics, was acquired by Knox Lane portfolio company Fingerpaint Group, an integrated collective of healthcare companies that offer commercialization solutions spanning the full product life cycle.
CROMSOURCE, an ISO-certified, leading European and global full-service contract research organization, was acquired by ClinChoice, a global clinical CRO dedicated to offering high-quality services to biopharmaceutical, vaccine, medical device, and consumer products companies. With corporate headquarters in Verona, Italy and US headquarters in Cary, NC, CROMSOURCE provides comprehensive clinical development services and staffing solutions to the world’s top biopharmaceutical and medical device companies.
“Fairmount’s team brings a unique understanding of both emerging technology and sell-side M&A. At Context, we had developed a market-disrupting software platform. Fairmount recognized the potential of what we had created and was able to help buyers understand that potential as well. That unique, out-of-the box perspective was critical to achieving a successful sale of the platform to Apex Group, a leading global provider of hedge fund software and services. We highly recommend Fairmount Partners.”
-Eric Noll, Chief Executive Officer, Context Capital Partners
Fairmount Partners is an independent investment banking firm focused on the needs of middle market and emerging growth companies. We help our clients complete mergers and acquisitions; raise funds for growth, acquisitions and liquidity; and design and improve their corporate development strategy. Our clients include successful entrepreneurs, private equity sponsored enterprises, and global public companies. With our expert advice and counsel, our clients have completed transactions in North and South America, Europe, Asia, Australia and the Middle East.
SELL SIDE MERGERS
BUY SIDE MERGERS
MINORITY AND MAJORITY EQUITY RECAPITALIZATIONS
At Fairmount Partners, our team of professionals aggressively deploys knowledge and expertise to benefit our clients. The team encompasses a vast range of skill sets including first-hand industry experience through in-depth transaction execution abilities.
FULL BIOS >>>
Below are links to several of the events that members of the Fairmount Partners team will be attending in the next several months. Please contact Peyton Embree to arrange a meeting or for further information.
For specific inquiries, please contact members of our team via phone or email addresses provided with their bios.
For any general inquiries, please fill in the following contact form: